Efficacy and safety of a single dose pentamidine (7mg/kg) for patients with cutaneous leishmaniasis caused by L. guyanensis: a pilot study

BACKGROUND: There have been few studies on pentamidine in the Americas; and there is no consensus regarding the dose that should be applied. OBJECTIVES: To evaluate the use of pentamidine in a single dose to treat cutaneous leishmaniasis. METHODS: Clinical trial of phase II pilot study with 20 patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Gadelha, Ellen Priscilla Nunes, Talhari, Sinésio, Guerra, Jorge Augusto de Oliveira, Neves, Leandro Ourives, Talhari, Carolina, Gontijo, Bernardo, da Silva Junior, Roberto Moreira, Talhari, Anette Chrusciak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Dermatologia 2015
Materias:
Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689067/
https://www.ncbi.nlm.nih.gov/pubmed/26734860
http://dx.doi.org/10.1590/abd1806-4841.20153956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689067/
https://www.ncbi.nlm.nih.gov/pubmed/26734860
http://dx.doi.org/10.1590/abd1806-4841.20153956

Ejemplares similares